View Older Stories

Oct 13, 2026 09:30AM Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days

Oct 7, 2026 09:45AM Cosmos Health posts $54.3M in nine-month revenue, up 19%

Oct 7, 2026 09:30AM Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million

Oct 1, 2026 03:58PM Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion

Sep 29, 2026 09:31AM CosmoFarm hits $60M annualized revenue run-rate in Q2 2026

Sep 29, 2026 09:30AM Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Reven

Sep 28, 2026 08:02AM Cosmos Health CMO pipeline tops 32.7M units with $20M implied revenue

Sep 28, 2026 08:00AM Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

Sep 15, 2026 10:31AM Cosmos Health unit signs 5.2M-unit deal with Target Pharma

Sep 15, 2026 10:30AM Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June

Sep 14, 2026 03:59PM Cosmos Health plans tokenized IP financing for hydrogel weight-loss device

Sep 14, 2026 03:59PM Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market

Sep 11, 2026 11:11AM Cosmos Health unit secures 2.5M-unit drug manufacturing deal with Viofar

Sep 11, 2026 11:10AM Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units

Sep 9, 2026 09:31AM Cosmos Health begins UK sales of veterinary antimicrobial C-ScrubVet

Sep 9, 2026 09:30AM Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market

Sep 3, 2026 09:33AM Cosmos Health reports record revenue, retires debt early in 2026

Aug 28, 2026 09:30AM Cosmos Health retires $8M convertible note a year early, buys back stock

Aug 24, 2026 03:40PM Cosmos Health projects $6M in annual revenue from new olive supplement

Aug 19, 2026 09:01AM Cosmos Health posts 29% revenue gain in Q2 but widens net loss

Jul 27, 2026 01:06PM Cosmos Health develops AI subscription platform for consumer health products

Jul 20, 2026 03:58PM Cosmos Health expands Albania distribution deal to 54,000 annual units

Jul 13, 2026 01:00PM Cosmos Health signs 5-year deal to sell diabetes drug in Greece

Jul 10, 2026 10:55AM Cosmos Health (COSM) Launches Subscription Model

Jul 1, 2026 11:05AM Cosmos Health buys back 2.65M shares for $500K under new program

Jun 25, 2026 03:35PM Cosmos Health files hydrogel weight loss patent in four markets

Jun 24, 2026 03:37PM Cosmos Health antiseptic product nears $1.3M in annualized sales in Greece

Jun 22, 2026 10:30AM Cosmos Health unit secures 25M-unit manufacturing orderbook

Jun 18, 2026 03:42PM CosmoFarm posts record Q2 2026 revenue above $15M

Jun 17, 2026 03:37PM Cosmos Health launches Korean collagen skincare line in the U.S.

Jun 15, 2026 09:00AM Cosmos Health projects over $22.7M revenue from four US products

Jun 12, 2026 09:29AM Cosmos Health reports $1.5m in antiseptic brand sales, eyes EU expansion

Jun 10, 2026 09:00AM Cosmos Health reports record $65.3M revenue, targets $200M by 2029

Jun 9, 2026 03:31PM Cosmos Health secures 5-year CERTORUN manufacturing deal worth 385,000 units

Jun 8, 2026 06:05AM Cosmos Health (COSM) files $200M mixed shelf

Jun 5, 2026 09:26AM Cosmos Health launches Oliv18 supplement in the US market

Jun 4, 2026 03:58PM Cosmos Health expands Sky Premium Life to all 27 EU states via Skroutz

Jun 4, 2026 09:28AM Cosmos Health identifies $20 million in non-core assets for potential sale

Jun 2, 2026 08:00AM Cosmos Health discusses European Investment Bank financing talks

Jun 1, 2026 08:27AM Cosmos Health enters animal health market with C-Scrub wash

May 26, 2026 09:34AM Cosmos Health issues 2026-2029 guidance targeting $200m revenue by 2029

May 21, 2026 02:27PM Cosmos Health lets 4.87 million Series B warrants expire unexercised

May 21, 2026 02:20PM Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026 09:16AM Cosmos Health reports record Q1 revenue of $17.9 million, up 31%

May 21, 2026 09:15AM Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with

May 14, 2026 09:03AM Cosmos Health secures advisory deal with European Investment Bank

May 14, 2026 09:00AM Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents

May 12, 2026 10:15AM Cosmos Health withdraws SEC registration statement for public offering

May 12, 2026 10:15AM Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 11, 2026 02:58PM Cosmos Health projects $3.2M revenue from Fort18 supplement launch

View Older Stories